About this trial
Pathological arthritis is a degenerative disease affecting the joints, characterized by pain, limitation of movement up to ankylosis and disability. Treatment is aimed at reducing pain and slowing the loss of functionality of the district. Among conservative treatments, pharmacological options (NSAIDs, cortisone, contrasupplements, hyaluronic acid) and non-pharmacological options (therapeutic exercise, physical therapy, orthosis, etc.) are indicated. In cases not responding to conservative treatments, surgical treatment will be necessary with prosthetic replacement of the joint district.
Eligibility criteria
Qualifiers
persistent knee pain for at least 3 months, measured with a VAS scale of 4 or higher,
clinical and radiological diagnosis confirming knee osteoarthritis grade 2 and 3 based on the Kellgren-Lawrence system,
no history of physical therapy in the last 3 months,
no infections, tumors in the treatment area of the knee,
Disqualifiers
inability to walk,
a history of clinically symptomatic spinal stenosis or lumbar radiculopathy,
evidence of a neurological disorder based on history or physical examination,
generalized pain or fibromyalgia,
Trial design
Treatments tested in this trial
- ESWT group
- exercise group